{
    "2018-04-19": [
        [
            {
                "time": "",
                "original_text": "看好中国 | 健康中国 ——创新药机会依旧",
                "features": {
                    "keywords": [
                        "健康中国",
                        "创新药",
                        "机会"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "两大主线得到市场认可",
                "features": {
                    "keywords": [
                        "两大主线",
                        "市场认可"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}